Selected research
Market Analysis & Forecast
Global Oocyte Cryopreservation Service Market Analysis and Forecast 2026-2032
Market perspective
The global Oocyte Cryopreservation Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Oocyte Cryopreservation Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Oocyte Cryopreservation Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Oocyte Cryopreservation Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Oocyte Cryopreservation Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Oocyte Cryopreservation Service include Prelude Fertility, CReATe Fertility Center, Anova Fertility, San Diego Fertility Center (SDFC), Extend Fertility, Shady Grove Fertility, Mayo Clinic, Reproductive Biology Associates and CCRM IVF, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Oocyte Cryopreservation Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Oocyte Cryopreservation Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Oocyte Cryopreservation Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Oocyte Cryopreservation Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Oocyte Cryopreservation Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Oocyte Cryopreservation Service revenue, projected growth trends, production technology, application and end-user industry.
Oocyte Cryopreservation Service Segment by Company
Prelude Fertility
CReATe Fertility Center
Anova Fertility
San Diego Fertility Center (SDFC)
Extend Fertility
Shady Grove Fertility
Mayo Clinic
Reproductive Biology Associates
CCRM IVF
HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group)
Kindbody
West Coast Fertility Centers
Ruizhimei
Oocyte Cryopreservation Service Segment by Type
Slow-cooling Method
Flash-freezing Process (Vitrification)
Oocyte Cryopreservation Service Segment by Application
25-30 Year Old Female
30-35 Year Old Female
35-40 Year Old Female
Others
Oocyte Cryopreservation Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oocyte Cryopreservation Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oocyte Cryopreservation Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oocyte Cryopreservation Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Oocyte Cryopreservation Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Oocyte Cryopreservation Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oocyte Cryopreservation Service revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Slow-cooling Method
- Flash-freezing Process (Vitrification)
Applications
- 25-30 Year Old Female
- 30-35 Year Old Female
- 35-40 Year Old Female
- Others
Companies covered
- Prelude Fertility
- CReATe Fertility Center
- Anova Fertility
- San Diego Fertility Center (SDFC)
- Extend Fertility
- Shady Grove Fertility
- Mayo Clinic
- Reproductive Biology Associates
- CCRM IVF
- HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group)
- Kindbody
- West Coast Fertility Centers
- Ruizhimei
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Oocyte Cryopreservation Service Market by Type
- 1.2.1 Global Oocyte Cryopreservation Service Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Slow-cooling Method
- 1.2.3 Flash-freezing Process (Vitrification)
- 1.3 Oocyte Cryopreservation Service Market by Application
- 1.3.1 Global Oocyte Cryopreservation Service Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 25-30 Year Old Female
- 1.3.3 30-35 Year Old Female
- 1.3.4 35-40 Year Old Female
- 1.3.5 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Oocyte Cryopreservation Service Market Dynamics
- 2.1 Oocyte Cryopreservation Service Industry Trends
- 2.2 Oocyte Cryopreservation Service Industry Drivers
- 2.3 Oocyte Cryopreservation Service Industry Opportunities and Challenges
- 2.4 Oocyte Cryopreservation Service Industry Restraints
3 Global Growth Perspective
- 3.1 Global Oocyte Cryopreservation Service Market Perspective (2021-2032)
- 3.2 Global Oocyte Cryopreservation Service Growth Trends by Region
- 3.2.1 Global Oocyte Cryopreservation Service Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Oocyte Cryopreservation Service Market Size by Region (2021-2026)
- 3.2.3 Global Oocyte Cryopreservation Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Oocyte Cryopreservation Service Revenue by Players
- 4.1.1 Global Oocyte Cryopreservation Service Revenue by Players (2021-2026)
- 4.1.2 Global Oocyte Cryopreservation Service Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Oocyte Cryopreservation Service Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Oocyte Cryopreservation Service Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Oocyte Cryopreservation Service Key Players Headquarters & Area Served
- 4.4 Global Oocyte Cryopreservation Service Players, Product Type & Application
- 4.5 Global Oocyte Cryopreservation Service Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Oocyte Cryopreservation Service Market CR5 and HHI
- 4.6.3 2025 Oocyte Cryopreservation Service Tier 1, Tier 2, and Tier 3
5 Oocyte Cryopreservation Service Market Size by Type
- 5.1 Global Oocyte Cryopreservation Service Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Oocyte Cryopreservation Service Revenue by Type (2021-2032)
- 5.3 Global Oocyte Cryopreservation Service Revenue Market Share by Type (2021-2032)
6 Oocyte Cryopreservation Service Market Size by Application
- 6.1 Global Oocyte Cryopreservation Service Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Oocyte Cryopreservation Service Revenue by Application (2021-2032)
- 6.3 Global Oocyte Cryopreservation Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Prelude Fertility
- 7.1.1 Prelude Fertility Company Information
- 7.1.2 Prelude Fertility Business Overview
- 7.1.3 Prelude Fertility Oocyte Cryopreservation Service Revenue and Gross Margin (2021-2026)
- 7.1.4 Prelude Fertility Oocyte Cryopreservation Service Product Portfolio
- 7.1.5 Prelude Fertility Recent Developments
- 7.2 CReATe Fertility Center
- 7.2.1 CReATe Fertility Center Company Information
- 7.2.2 CReATe Fertility Center Business Overview
- 7.2.3 CReATe Fertility Center Oocyte Cryopreservation Service Revenue and Gross Margin (2021-2026)
- 7.2.4 CReATe Fertility Center Oocyte Cryopreservation Service Product Portfolio
- 7.2.5 CReATe Fertility Center Recent Developments
- 7.3 Anova Fertility
- 7.3.1 Anova Fertility Company Information
- 7.3.2 Anova Fertility Business Overview
- 7.3.3 Anova Fertility Oocyte Cryopreservation Service Revenue and Gross Margin (2021-2026)
- 7.3.4 Anova Fertility Oocyte Cryopreservation Service Product Portfolio
- 7.3.5 Anova Fertility Recent Developments
- 7.4 San Diego Fertility Center (SDFC)
- 7.4.1 San Diego Fertility Center (SDFC) Company Information
- 7.4.2 San Diego Fertility Center (SDFC) Business Overview
- 7.4.3 San Diego Fertility Center (SDFC) Oocyte Cryopreservation Service Revenue and Gross Margin (2021-2026)
- 7.4.4 San Diego Fertility Center (SDFC) Oocyte Cryopreservation Service Product Portfolio
- 7.4.5 San Diego Fertility Center (SDFC) Recent Developments
- 7.5 Extend Fertility
- 7.5.1 Extend Fertility Company Information
- 7.5.2 Extend Fertility Business Overview
- 7.5.3 Extend Fertility Oocyte Cryopreservation Service Revenue and Gross Margin (2021-2026)
- 7.5.4 Extend Fertility Oocyte Cryopreservation Service Product Portfolio
- 7.5.5 Extend Fertility Recent Developments
- 7.6 Shady Grove Fertility
- 7.6.1 Shady Grove Fertility Company Information
- 7.6.2 Shady Grove Fertility Business Overview
- 7.6.3 Shady Grove Fertility Oocyte Cryopreservation Service Revenue and Gross Margin (2021-2026)
- 7.6.4 Shady Grove Fertility Oocyte Cryopreservation Service Product Portfolio
- 7.6.5 Shady Grove Fertility Recent Developments
- 7.7 Mayo Clinic
- 7.7.1 Mayo Clinic Company Information
- 7.7.2 Mayo Clinic Business Overview
- 7.7.3 Mayo Clinic Oocyte Cryopreservation Service Revenue and Gross Margin (2021-2026)
- 7.7.4 Mayo Clinic Oocyte Cryopreservation Service Product Portfolio
- 7.7.5 Mayo Clinic Recent Developments
- 7.8 Reproductive Biology Associates
- 7.8.1 Reproductive Biology Associates Company Information
- 7.8.2 Reproductive Biology Associates Business Overview
- 7.8.3 Reproductive Biology Associates Oocyte Cryopreservation Service Revenue and Gross Margin (2021-2026)
- 7.8.4 Reproductive Biology Associates Oocyte Cryopreservation Service Product Portfolio
- 7.8.5 Reproductive Biology Associates Recent Developments
- 7.9 CCRM IVF
- 7.9.1 CCRM IVF Company Information
- 7.9.2 CCRM IVF Business Overview
- 7.9.3 CCRM IVF Oocyte Cryopreservation Service Revenue and Gross Margin (2021-2026)
- 7.9.4 CCRM IVF Oocyte Cryopreservation Service Product Portfolio
- 7.9.5 CCRM IVF Recent Developments
- 7.10 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group)
- 7.10.1 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Company Information
- 7.10.2 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Business Overview
- 7.10.3 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Oocyte Cryopreservation Service Revenue and Gross Margin (2021-2026)
- 7.10.4 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Oocyte Cryopreservation Service Product Portfolio
- 7.10.5 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Recent Developments
- 7.11 Kindbody
- 7.11.1 Kindbody Company Information
- 7.11.2 Kindbody Business Overview
- 7.11.3 Kindbody Oocyte Cryopreservation Service Revenue and Gross Margin (2021-2026)
- 7.11.4 Kindbody Oocyte Cryopreservation Service Product Portfolio
- 7.11.5 Kindbody Recent Developments
- 7.12 West Coast Fertility Centers
- 7.12.1 West Coast Fertility Centers Company Information
- 7.12.2 West Coast Fertility Centers Business Overview
- 7.12.3 West Coast Fertility Centers Oocyte Cryopreservation Service Revenue and Gross Margin (2021-2026)
- 7.12.4 West Coast Fertility Centers Oocyte Cryopreservation Service Product Portfolio
- 7.12.5 West Coast Fertility Centers Recent Developments
- 7.13 Ruizhimei
- 7.13.1 Ruizhimei Company Information
- 7.13.2 Ruizhimei Business Overview
- 7.13.3 Ruizhimei Oocyte Cryopreservation Service Revenue and Gross Margin (2021-2026)
- 7.13.4 Ruizhimei Oocyte Cryopreservation Service Product Portfolio
- 7.13.5 Ruizhimei Recent Developments
8 North America
- 8.1 North America Oocyte Cryopreservation Service Revenue (2021-2032)
- 8.2 North America Oocyte Cryopreservation Service Revenue by Type (2021-2032)
- 8.2.1 North America Oocyte Cryopreservation Service Revenue by Type (2021-2026)
- 8.2.2 North America Oocyte Cryopreservation Service Revenue by Type (2027-2032)
- 8.3 North America Oocyte Cryopreservation Service Revenue Share by Type (2021-2032)
- 8.4 North America Oocyte Cryopreservation Service Revenue by Application (2021-2032)
- 8.4.1 North America Oocyte Cryopreservation Service Revenue by Application (2021-2026)
- 8.4.2 North America Oocyte Cryopreservation Service Revenue by Application (2027-2032)
- 8.5 North America Oocyte Cryopreservation Service Revenue Share by Application (2021-2032)
- 8.6 North America Oocyte Cryopreservation Service Revenue by Country
- 8.6.1 North America Oocyte Cryopreservation Service Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Oocyte Cryopreservation Service Revenue by Country (2021-2026)
- 8.6.3 North America Oocyte Cryopreservation Service Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Oocyte Cryopreservation Service Revenue (2021-2032)
- 9.2 Europe Oocyte Cryopreservation Service Revenue by Type (2021-2032)
- 9.2.1 Europe Oocyte Cryopreservation Service Revenue by Type (2021-2026)
- 9.2.2 Europe Oocyte Cryopreservation Service Revenue by Type (2027-2032)
- 9.3 Europe Oocyte Cryopreservation Service Revenue Share by Type (2021-2032)
- 9.4 Europe Oocyte Cryopreservation Service Revenue by Application (2021-2032)
- 9.4.1 Europe Oocyte Cryopreservation Service Revenue by Application (2021-2026)
- 9.4.2 Europe Oocyte Cryopreservation Service Revenue by Application (2027-2032)
- 9.5 Europe Oocyte Cryopreservation Service Revenue Share by Application (2021-2032)
- 9.6 Europe Oocyte Cryopreservation Service Revenue by Country
- 9.6.1 Europe Oocyte Cryopreservation Service Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Oocyte Cryopreservation Service Revenue by Country (2021-2026)
- 9.6.3 Europe Oocyte Cryopreservation Service Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Oocyte Cryopreservation Service Revenue (2021-2032)
- 10.2 China Oocyte Cryopreservation Service Revenue by Type (2021-2032)
- 10.2.1 China Oocyte Cryopreservation Service Revenue by Type (2021-2026)
- 10.2.2 China Oocyte Cryopreservation Service Revenue by Type (2027-2032)
- 10.3 China Oocyte Cryopreservation Service Revenue Share by Type (2021-2032)
- 10.4 China Oocyte Cryopreservation Service Revenue by Application (2021-2032)
- 10.4.1 China Oocyte Cryopreservation Service Revenue by Application (2021-2026)
- 10.4.2 China Oocyte Cryopreservation Service Revenue by Application (2027-2032)
- 10.5 China Oocyte Cryopreservation Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Oocyte Cryopreservation Service Revenue (2021-2032)
- 11.2 Asia Oocyte Cryopreservation Service Revenue by Type (2021-2032)
- 11.2.1 Asia Oocyte Cryopreservation Service Revenue by Type (2021-2026)
- 11.2.2 Asia Oocyte Cryopreservation Service Revenue by Type (2027-2032)
- 11.3 Asia Oocyte Cryopreservation Service Revenue Share by Type (2021-2032)
- 11.4 Asia Oocyte Cryopreservation Service Revenue by Application (2021-2032)
- 11.4.1 Asia Oocyte Cryopreservation Service Revenue by Application (2021-2026)
- 11.4.2 Asia Oocyte Cryopreservation Service Revenue by Application (2027-2032)
- 11.5 Asia Oocyte Cryopreservation Service Revenue Share by Application (2021-2032)
- 11.6 Asia Oocyte Cryopreservation Service Revenue by Country
- 11.6.1 Asia Oocyte Cryopreservation Service Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Oocyte Cryopreservation Service Revenue by Country (2021-2026)
- 11.6.3 Asia Oocyte Cryopreservation Service Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Oocyte Cryopreservation Service Revenue (2021-2032)
- 12.2 SAMEA Oocyte Cryopreservation Service Revenue by Type (2021-2032)
- 12.2.1 SAMEA Oocyte Cryopreservation Service Revenue by Type (2021-2026)
- 12.2.2 SAMEA Oocyte Cryopreservation Service Revenue by Type (2027-2032)
- 12.3 SAMEA Oocyte Cryopreservation Service Revenue Share by Type (2021-2032)
- 12.4 SAMEA Oocyte Cryopreservation Service Revenue by Application (2021-2032)
- 12.4.1 SAMEA Oocyte Cryopreservation Service Revenue by Application (2021-2026)
- 12.4.2 SAMEA Oocyte Cryopreservation Service Revenue by Application (2027-2032)
- 12.5 SAMEA Oocyte Cryopreservation Service Revenue Share by Application (2021-2032)
- 12.6 SAMEA Oocyte Cryopreservation Service Revenue by Country
- 12.6.1 SAMEA Oocyte Cryopreservation Service Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Oocyte Cryopreservation Service Revenue by Country (2021-2026)
- 12.6.3 SAMEA Oocyte Cryopreservation Service Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst